Down to Halves

3655

By: Radha McLean

Novo Nordisk, of Princeton, New Jersey, has received approval from the U.S. Food and Drug Administration for a new insulin delivery system with a special feature and design.

The colorful NovoPen Junior, an extension of the company’s NovoPen line, delivers 1 to 35 units of insulin in half-unit dose increments. It was designed for children and teenagers on insulin therapy, who typically use smaller amounts of insulin, and for adults who need the flexibility to fine-tune their insulin dosages, according to a news release from Novo Nordisk.

Comments

comments

Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.